Details for New Drug Application (NDA): 065027
✉ Email this page to a colleague
NDA 065027 describes CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by Abbott Labs and Baxter Hlthcare and is included in two NDAs. Additional details are available on the CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
The generic ingredient in CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Summary for 065027
| Tradename: | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | Abbott Labs |
| Ingredient: | clindamycin phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 6MG BASE/ML | ||||
| Approval Date: | Jun 29, 2001 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 12MG BASE/ML | ||||
| Approval Date: | Jun 29, 2001 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 18MG BASE/ML | ||||
| Approval Date: | Jun 29, 2001 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
